Year-to-year variation in attack rates could result in underpowered respiratory syncytial virus vaccine efficacy trials.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Billard, Marie-NoëlleWildenbeest, Joanne
Bont, Louis J
Nair, Harish
McCracken, John P
Oude Rengerink, Katrien
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
Year-to-year variation in attack rates could result in underpowered respiratory syncytial virus vaccine efficacy trials.Published in
Journal of clinical epidemiology 2022;147:11-20PMID
35217153ae974a485f413a2113503eed53cd6c53
10.1016/j.jclinepi.2022.02.003
Scopus Count
Collections